ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis, Epidemiology, Smoking RFAs Get DCCP Board Okay

June 12, 1981

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

September 9, 2005

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

RFA On Hepatitis B Virus, Liver Cancer

April 15, 1983

NIH Seeking Nominations for Review Committees

February 23, 1979